- call +1-201-465-4211
- email sales@mrinsights.biz
Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults.
Scope of the Report:
The worldwide market for Acromegaly is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Acromegaly in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Novartis
Aegis Therapeutics
Chiasma
Crinetics Pharmaceuticals
Daewoong Pharmaceutical
Peptron
Silence Therapeutics
Strongbridge Biopharma
Amryt Pharma
Foresee Pharmaceuticals
Glide Pharmaceutical
Ionis Pharmaceuticals
Ipsen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
Market Segment by Applications, can be divided into
Hospitals
Clinics
There are 15 Chapters to deeply display the global Acromegaly market.
Chapter 1, to describe Acromegaly Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Acromegaly, with sales, revenue, and price of Acromegaly, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Acromegaly, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Acromegaly market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Acromegaly sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Acromegaly Introduction
1.2 Market Analysis by Type
1.2.1 Somatostatin Analogues
1.2.2 Dopamine Agonists
1.2.3 Growth Hormone Receptor Antagonists
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Acromegaly Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Aegis Therapeutics
2.2.1 Business Overview
2.2.2 Acromegaly Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Aegis Therapeutics Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Chiasma
2.3.1 Business Overview
2.3.2 Acromegaly Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Chiasma Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Crinetics Pharmaceuticals
2.4.1 Business Overview
2.4.2 Acromegaly Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Crinetics Pharmaceuticals Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Daewoong Pharmaceutical
2.5.1 Business Overview
2.5.2 Acromegaly Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Daewoong Pharmaceutical Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Peptron
2.6.1 Business Overview
2.6.2 Acromegaly Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Peptron Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Silence Therapeutics
2.7.1 Business Overview
2.7.2 Acromegaly Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Silence Therapeutics Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Strongbridge Biopharma
2.8.1 Business Overview
2.8.2 Acromegaly Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Strongbridge Biopharma Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Amryt Pharma
2.9.1 Business Overview
2.9.2 Acromegaly Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Amryt Pharma Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Foresee Pharmaceuticals
2.10.1 Business Overview
2.10.2 Acromegaly Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Foresee Pharmaceuticals Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Glide Pharmaceutical
2.11.1 Business Overview
2.11.2 Acromegaly Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Glide Pharmaceutical Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Ionis Pharmaceuticals
2.12.1 Business Overview
2.12.2 Acromegaly Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Ionis Pharmaceuticals Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Ipsen
2.13.1 Business Overview
2.13.2 Acromegaly Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Ipsen Acromegaly Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Acromegaly Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Acromegaly Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Acromegaly Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Acromegaly Manufacturer Market Share in 2017
3.3.2 Top 6 Acromegaly Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Acromegaly Market Analysis by Regions
4.1 Global Acromegaly Sales, Revenue and Market Share by Regions
4.1.1 Global Acromegaly Sales and Market Share by Regions (2013-2018)
4.1.2 Global Acromegaly Revenue and Market Share by Regions (2013-2018)
4.2 North America Acromegaly Sales and Growth Rate (2013-2018)
4.3 Europe Acromegaly Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Acromegaly Sales and Growth Rate (2013-2018)
4.5 South America Acromegaly Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Acromegaly Sales and Growth Rate (2013-2018)
5 North America Acromegaly by Countries
5.1 North America Acromegaly Sales, Revenue and Market Share by Countries
5.1.1 North America Acromegaly Sales and Market Share by Countries (2013-2018)
5.1.2 North America Acromegaly Revenue and Market Share by Countries (2013-2018)
5.2 United States Acromegaly Sales and Growth Rate (2013-2018)
5.3 Canada Acromegaly Sales and Growth Rate (2013-2018)
5.4 Mexico Acromegaly Sales and Growth Rate (2013-2018)
6 Europe Acromegaly by Countries
6.1 Europe Acromegaly Sales, Revenue and Market Share by Countries
6.1.1 Europe Acromegaly Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Acromegaly Revenue and Market Share by Countries (2013-2018)
6.2 Germany Acromegaly Sales and Growth Rate (2013-2018)
6.3 UK Acromegaly Sales and Growth Rate (2013-2018)
6.4 France Acromegaly Sales and Growth Rate (2013-2018)
6.5 Russia Acromegaly Sales and Growth Rate (2013-2018)
6.6 Italy Acromegaly Sales and Growth Rate (2013-2018)
7 Asia-Pacific Acromegaly by Countries
7.1 Asia-Pacific Acromegaly Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Acromegaly Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Acromegaly Revenue and Market Share by Countries (2013-2018)
7.2 China Acromegaly Sales and Growth Rate (2013-2018)
7.3 Japan Acromegaly Sales and Growth Rate (2013-2018)
7.4 Korea Acromegaly Sales and Growth Rate (2013-2018)
7.5 India Acromegaly Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Acromegaly Sales and Growth Rate (2013-2018)
8 South America Acromegaly by Countries
8.1 South America Acromegaly Sales, Revenue and Market Share by Countries
8.1.1 South America Acromegaly Sales and Market Share by Countries (2013-2018)
8.1.2 South America Acromegaly Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Acromegaly Sales and Growth Rate (2013-2018)
8.3 Argentina Acromegaly Sales and Growth Rate (2013-2018)
8.4 Colombia Acromegaly Sales and Growth Rate (2013-2018)
9 Middle East and Africa Acromegaly by Countries
9.1 Middle East and Africa Acromegaly Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Acromegaly Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Acromegaly Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Acromegaly Sales and Growth Rate (2013-2018)
9.3 UAE Acromegaly Sales and Growth Rate (2013-2018)
9.4 Egypt Acromegaly Sales and Growth Rate (2013-2018)
9.5 Nigeria Acromegaly Sales and Growth Rate (2013-2018)
9.6 South Africa Acromegaly Sales and Growth Rate (2013-2018)
10 Global Acromegaly Market Segment by Type
10.1 Global Acromegaly Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Acromegaly Sales and Market Share by Type (2013-2018)
10.1.2 Global Acromegaly Revenue and Market Share by Type (2013-2018)
10.2 Somatostatin Analogues Sales Growth and Price
10.2.1 Global Somatostatin Analogues Sales Growth (2013-2018)
10.2.2 Global Somatostatin Analogues Price (2013-2018)
10.3 Dopamine Agonists Sales Growth and Price
10.3.1 Global Dopamine Agonists Sales Growth (2013-2018)
10.3.2 Global Dopamine Agonists Price (2013-2018)
10.4 Growth Hormone Receptor Antagonists Sales Growth and Price
10.4.1 Global Growth Hormone Receptor Antagonists Sales Growth (2013-2018)
10.4.2 Global Growth Hormone Receptor Antagonists Price (2013-2018)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2013-2018)
10.5.2 Global Other Price (2013-2018)
11 Global Acromegaly Market Segment by Application
11.1 Global Acromegaly Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
12 Acromegaly Market Forecast (2018-2023)
12.1 Global Acromegaly Sales, Revenue and Growth Rate (2018-2023)
12.2 Acromegaly Market Forecast by Regions (2018-2023)
12.2.1 North America Acromegaly Market Forecast (2018-2023)
12.2.2 Europe Acromegaly Market Forecast (2018-2023)
12.2.3 Asia-Pacific Acromegaly Market Forecast (2018-2023)
12.2.4 South America Acromegaly Market Forecast (2018-2023)
12.2.5 Middle East and Africa Acromegaly Market Forecast (2018-2023)
12.3 Acromegaly Market Forecast by Type (2018-2023)
12.3.1 Global Acromegaly Sales Forecast by Type (2018-2023)
12.3.2 Global Acromegaly Market Share Forecast by Type (2018-2023)
12.4 Acromegaly Market Forecast by Application (2018-2023)
12.4.1 Global Acromegaly Sales Forecast by Application (2018-2023)
12.4.2 Global Acromegaly Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Acromegaly Picture
Table Product Specifications of Acromegaly
Figure Global Sales Market Share of Acromegaly by Types in 2017
Table Acromegaly Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
